Israel Active

An international study, led by Ben Gurion University Professor Iris Shai, has shown that the green Mediterranean (MED) diet modifies the bacterial population in the gut. These changes in the microbiome can bring substantial health benefits, including reduced cardiac risk.

Professor Sara Eyal of the Hebrew University of Jerusalem has launched Israel’s first university course for therapy development research in space, or “space medicine.”  Her first session attracted some 40 students from different disciplines such as medicine, pharmacy, nursing, and biology.

Israel and Bahrain have signed an agreement for health care cooperation in epidemics and emergency management, education, and research.  It will cover the fields of information sharing, digital health, medical innovation, and genetic research.

A Technion doctorate student has discovered that the LOX enzyme plays a major role in helping cancer spread (metastasis) when the patient is having chemotherapy. Inhibiting LOX protects the patient from this deadly effect.

Israel’s Sheba Medical Center has again been ranked as the 10th best hospital in the world by Newsweek Magazine. Sheba also announced a partnership with GE Healthcare to develop digital healthcare solutions in cardiology, remote pregnancy monitoring and molecular imaging.

Several issues of the international journal Advanced Materials, including cover pages, feature the breakthrough skin patches developed in the lab of Israel’s Technion Arab Professor Hossam Haick (see previously). They include , (and ), , and .

Illumina - the world's leading DNA sequencing company, worth over $50 billion, is opening a Center of Excellence in Tel Aviv. It will develop Artificial Intelligence (AI) solutions that dramatically shorten genome analysis time for diagnosing rare diseases and transform lives.

Israel’s AEYE Health (see previously) has just completed Phase 3 clinical trials of its hand-held retinal analysis system. The hand-held fundus camera and single-image AI software detected diabetic retinopathy with high accuracy, far better than current expensive specialist cameras.

Israel’s OneStep uses the power of the smartphone to analyze gait (how you walk) and provide feedback directly to patients and their physical therapists. OneStep is partnering with Kinomatic in the US to bring OneStep’s app to all patients using Kinomatic's Virtual Reality solution.

The ELGN-GI insulin formulation developed by Israel’s Elgan can save the lives of preterm babies with immature stomachs that cause feeding intolerance. It will avoid the adverse effects of intravenous nutrition, which often leads to infection and liver problems. A Phase 3 trial is being planned.